Denmark · Funded startup

Who invested in IO Biotech

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$6.6Mraised across 1 round since 2025, from 1 source

Latest round
Round, $6.6MSept 2025
Investors
4
See who backed them

The rounds

  1. Sept 2025

Founders and team

From IO Biotech's own website: 2 on the team.

  • Amy SullivanChief Financial Officer
  • Devin SmithGeneral Counsel

Everyone who backed them

RA Capital ManagementPrivate equity1round
European Investment BankGovernment1round
Vivo CapitalPrivate equity1round
Samsara BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list IO Biotech as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

KurmaPartnersVC firmPer its own site
EIR VenturesVC firmPer its own site

Quick answers about IO Biotech

Who invested in IO Biotech?

IO Biotech's investors include RA Capital Management, European Investment Bank, Vivo Capital and Samsara BioCapital.

How much has IO Biotech raised?

IO Biotech has raised $6.6M across 1 round since 2025.

When did IO Biotech last raise?

IO Biotech's most recent round was an Undisclosed round of $6.6M in Sept 2025.

What was IO Biotech's biggest round?

Its most recent round, $6.6M in Sept 2025, is also its largest on record.

Who backed IO Biotech first?

IO Biotech's first round on record, in Sept 2025, was backed by RA Capital Management, European Investment Bank and Vivo Capital and 1 others.

What stage is IO Biotech at?

IO Biotech's latest named round is an Undisclosed round, in Sept 2025.

Where is IO Biotech based?

IO Biotech is based in Denmark.

Companies like IO Biotech

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.